Invention Grant
- Patent Title: Hydroxamic acid derivative
- Patent Title (中): 羟肟酸衍生物
-
Application No.: US13642320Application Date: 2011-04-20
-
Publication No.: US09073821B2Publication Date: 2015-07-07
- Inventor: Hajime Takashima , Risa Tsuruta , Tetsuya Yabuuchi , Yusuke Oka , Hiroki Urabe , Yoichiro Suga , Masato Takahashi , Fumito Uneuchi , Hironori Kotsubo , Muneo Shoji , Yasuko Kawaguchi
- Applicant: Hajime Takashima , Risa Tsuruta , Tetsuya Yabuuchi , Yusuke Oka , Hiroki Urabe , Yoichiro Suga , Masato Takahashi , Fumito Uneuchi , Hironori Kotsubo , Muneo Shoji , Yasuko Kawaguchi
- Applicant Address: JP Tokyo JP Tokyo
- Assignee: TAISHO PHARMACEUTICAL CO., LTD,TOYAMA CHEMICAL CO., LTD.
- Current Assignee: TAISHO PHARMACEUTICAL CO., LTD,TOYAMA CHEMICAL CO., LTD.
- Current Assignee Address: JP Tokyo JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2010-096852 20100420
- International Application: PCT/JP2011/059737 WO 20110420
- International Announcement: WO2011/132712 WO 20111027
- Main IPC: C07C259/06
- IPC: C07C259/06 ; C07C323/62 ; C07D305/06 ; C07D307/14 ; C07D317/30 ; C07D319/18 ; C07D295/08 ; C07D285/12 ; C07D271/12 ; C07D265/30 ; C07D263/14 ; C07D261/08 ; C07D241/04 ; C07C271/22 ; C07C271/28 ; C07C311/08 ; C07C317/28 ; C07C317/44 ; C07C323/41 ; C07D205/12 ; C07D207/12 ; C07D207/27 ; C07D207/327 ; C07D209/12 ; C07D209/14 ; C07D209/44 ; C07D209/52 ; C07D211/18 ; C07D211/38 ; C07D211/46 ; C07D211/56 ; C07D211/70 ; C07D213/38 ; C07D213/40 ; C07D213/54 ; C07D213/61 ; C07D213/64 ; C07D213/65 ; C07D213/70 ; C07D213/74 ; C07D213/81 ; C07D215/14 ; C07D217/12 ; C07D231/56 ; C07D257/04 ; C07D263/32 ; C07D263/56 ; C07D265/38 ; C07D267/10 ; C07D277/20 ; C07D277/30 ; C07D277/62 ; C07D277/66 ; C07D295/12 ; C07D295/14 ; C07D295/16 ; C07D305/08 ; C07D307/18 ; C07D307/52 ; C07D307/54 ; C07D307/78 ; C07D307/82 ; C07D307/87 ; C07D309/04 ; C07D309/14 ; C07D317/60 ; C07D319/20 ; C07D333/24 ; C07D405/06 ; C07D413/06 ; C07D471/04 ; C07D471/10 ; C07D487/08 ; C07D491/20 ; C07D498/08 ; C07F9/09 ; C07D239/26 ; C07D235/04 ; C07D233/61 ; C07D231/12 ; C07D217/04 ; C07D211/14 ; C07D209/08 ; C07D207/10 ; C07D205/04
Abstract:
Provided is a novel compound which is useful as a pharmaceutical composition by inhibiting an LpxC activity, thereby exhibiting potent antimicrobial activity against gram-negative bacteria including Pseudomonas aeruginosa and its drug resistant bacteria. Provided is a hydroxamic acid derivative represented by the following general formula [1] or a pharmaceutically acceptable salt thereof:
Public/Granted literature
- US20130072677A1 NOVEL HYDROXAMIC ACID DERIVATIVE Public/Granted day:2013-03-21
Information query
